RYAM vs UTHR · rev $695.2M vs P/E 20, rev $1.56B
Rayonier Advanced Materials (RYAM) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Rayonier Advanced Materials (RYAM) is a chemicals company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported RYAM revenue for 2026-06-27 was $695.2M. Net income was -$114.4M. RYAM currently screens at market cap $242.4M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
RYAM currently screens at market cap $242.4M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the RYAM and UTHR stock pages for the full models.
Not investment advice.